| C07AG02 |
Carvedilol |
CARVEDILOL SOPHARMA 6.25 |
Tablet |
6.25 |
mg |
30 |
Софарма АД, България |
37.5 |
mg |
- |
2.12 |
0.212 |
1.06 |
50% |
0.53 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.8,I20.9,I25.5,I50.0,I50.1 |
КЦРР-585/10.05.2012 г.; НСР-16423/09.08.2018 |
02.09.2018 |
08.09.2012 |
|
Активен |
1132 |
| C07AG02 |
Carvedilol |
CARVETREND |
Tablet |
12.5 |
mg |
28 |
Teva B.V., Нидерландия |
37.5 |
mg |
- |
7.9 |
0.212 |
1.98 |
50% |
0.99 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.8,I20.9,I25.5,I50.0,I50.1 |
НСР-17558/20.12.2018; НСР-18844/30.05.2019 |
02.07.2019 |
|
|
Активен |
389 |
| C07AG02 |
Carvedilol |
CARVETREND |
Tablet |
6.25 |
mg |
28 |
Teva B.V., Нидерландия |
37.5 |
mg |
- |
3.96 |
0.212 |
0.99 |
50% |
0.49 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.8,I20.9,I25.5,I50.0,I50.1 |
НСР-17558/20.12.2018; НСР-18844/30.05.2019 |
02.07.2019 |
|
|
Активен |
388 |
| C07AG02 |
Carvedilol |
CARVETREND |
Tablet |
25 |
mg |
28 |
Teva B.V., Нидерландия |
37.5 |
mg |
- |
15.43 |
0.212 |
3.96 |
50% |
1.98 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.8,I20.9,I25.5,I50.0,I50.1 |
НСР-17558/20.12.2018; НСР-18844/30.05.2019 |
02.07.2019 |
|
|
Активен |
390 |
| C07AG02 |
Carvedilol |
CARVETREND |
Tablet |
25 |
mg |
28 |
Екофарм Груп АД, България |
37.5 |
mg |
- |
7.9 |
0.212 |
3.96 |
50% |
1.98 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.8,I20.9,I25.5,I50.0,I50.1 |
HCP-160/18.06.2013.; КП-36/30.05.2018 и НСР-15340/30.03.2018; НСР-16063/29.06.2018 предварително изпълнение |
02.07.2018 |
08.09.2012 |
|
Заличен |
390 |
| C07AG02 |
Carvedilol |
CARVETREND |
Tablet |
12.5 |
mg |
28 |
Екофарм Груп АД, България |
37.5 |
mg |
- |
3.96 |
0.212 |
1.98 |
50% |
0.99 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.8,I20.9,I25.5,I50.0,I50.1 |
HCP-160/18.06.2013.; КП-37/30.05.2018 и НСР-15339/30.03.2018; НСР-16062/29.06.2018 предварително изпълнение |
02.07.2018 |
08.09.2012 |
|
Заличен |
389 |
| C07AG02 |
Carvedilol |
CARVETREND |
Tablet |
6.25 |
mg |
28 |
Екофарм Груп АД, България |
37.5 |
mg |
- |
1.98 |
0.212 |
0.99 |
50% |
0.49 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.8,I20.9,I25.5,I50.0,I50.1 |
HCP-160/18.06.2013.; КП-38/30.05.2018 и НСР-15338/30.03.2018; НСР-16061/29.06.2018 предварително изпълнение |
02.07.2018 |
08.09.2012 |
|
Заличен |
388 |
| C07AG02 |
Carvedilol |
CARVILEX |
Tablet |
6.25 |
mg |
30 |
Актавис EАД, България |
37.5 |
mg |
- |
5.81 |
0.212 |
1.06 |
50% |
0.53 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.8,I20.9,I25.5,I50.0,I50.1 |
НСР-19011/20.06.2019 |
02.08.2019 |
08.09.2012 |
|
Активен |
246 |
| C07AG02 |
Carvedilol |
CARVILEX |
Tablet |
12.5 |
mg |
30 |
Актавис EАД, България |
37.5 |
mg |
- |
10.96 |
0.212 |
2.12 |
50% |
1.06 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.8,I20.9,I25.5,I50.0,I50.1 |
НСР-19010/20.06.2019 |
02.08.2019 |
08.09.2012 |
|
Активен |
247 |
| C07AG02 |
Carvedilol |
CARVILEX |
Tablet |
25 |
mg |
30 |
Актавис EАД, България |
37.5 |
mg |
- |
23.9 |
0.212 |
4.24 |
50% |
2.12 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.8,I20.9,I25.5,I50.0,I50.1 |
НСР-19012/20.06.2019 |
02.08.2019 |
08.09.2012 |
|
Активен |
248 |
| C07AG02 |
Carvedilol |
Coryol |
Tablet |
12.5 |
mg |
28 |
KRKA, d.d., Словения |
37.5 |
mg |
- |
3.19 |
0.212 |
1.98 |
50% |
0.99 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.8,I20.9,I25.5,I50.0,I50.1 |
№ 238/ 04.11.2011; НСР-921/12.08.2013; НСР-10672/21.10.2016 |
02.12.2016 |
08.09.2012 |
|
Активен |
2054 |
| C07AG02 |
Carvedilol |
Coryol |
Tablet |
6.25 |
mg |
28 |
KRKA, d.d., Словения |
37.5 |
mg |
- |
2.41 |
0.212 |
0.99 |
50% |
0.49 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.8,I20.9,I25.5,I50.0,I50.1 |
№ 238/ 04.11.2011; НСР-10023/18.08.2016 |
02.10.2016 |
08.09.2012 |
|
Активен |
929 |
| C07AG02 |
Carvedilol |
Coryol |
Tablet |
25 |
mg |
28 |
KRKA, d.d., Словения |
37.5 |
mg |
- |
4.36 |
0.212 |
3.96 |
50% |
1.98 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.8,I20.9,I25.5,I50.0,I50.1 |
НСР-8233/22.02.2016 |
02.04.2016 |
08.09.2012 |
|
Активен |
292 |
| C07AG02 |
Carvedilol |
Dilatrend |
Tablet |
25 |
mg |
28 |
Чайкафарма Висококачествените лекарства АД, България |
37.5 |
mg |
- |
15.44 |
0.212 |
3.96 |
50% |
1.98 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.8,I20.9,I25.5,I50.0,I50.1 |
НСР-4824/13.10.2014; НСР-17664/02.01.2019 и КП-85/11.11.2019 |
02.01.2020 |
|
|
Активен |
3225 |
| C07AG02 |
Carvedilol |
Dilatrend |
Tablet |
6.25 |
mg |
28 |
Чайкафарма Висококачествените лекарства АД, България |
37.5 |
mg |
- |
5.42 |
0.212 |
0.99 |
50% |
0.49 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.8,I20.9,I25.5,I50.0,I50.1 |
НСР-4824/13.10.2014; НСР-18137/07.03.2019 |
02.04.2019 |
|
|
Активен |
3227 |
| C07AG02 |
Carvedilol |
Dilatrend |
Tablet |
12.5 |
mg |
28 |
Чайкафарма Висококачествените лекарства АД, България |
37.5 |
mg |
- |
10.22 |
0.212 |
1.98 |
50% |
0.99 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.8,I20.9,I25.5,I50.0,I50.1 |
НСР-4824/13.10.2014; НСР-18135/07.03.2019 |
02.04.2019 |
|
|
Активен |
3226 |
| C07AG02 |
Carvedilol |
Dilatrend |
Tablet |
25 |
mg |
28 |
Рош България ЕООД, България |
37.5 |
mg |
- |
12.82 |
0.225 |
4.2 |
50% |
2.1 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.8,I20.9,I25.5,I50.0,I50.1 |
КЦРР-837/15.06.2012 и КП-196/24.04.2013; НСР-3567/23.05.2014 |
16.06.2014 |
|
|
Заличен |
3225 |
| C07AG02 |
Carvedilol |
Dilatrend |
Tablet |
12.5 |
mg |
28 |
Рош България ЕООД, България |
37.5 |
mg |
- |
13.58 |
0.225 |
2.1 |
50% |
1.05 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.8,I20.9,I25.5,I50.0,I50.1 |
КЦРР-837/15.06.2012 и КП-196/24.04.2013; НСР-3567/23.05.2014 |
16.06.2014 |
|
|
Заличен |
3226 |
| C07AG02 |
Carvedilol |
Dilatrend |
Tablet |
6.25 |
mg |
28 |
Рош България ЕООД, България |
37.5 |
mg |
- |
5.72 |
0.225 |
1.05 |
50% |
0.53 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.8,I20.9,I25.5,I50.0,I50.1 |
КЦРР-837/15.06.2012 и КП-196/24.04.2013; НСР-3567/23.05.2014 |
16.06.2014 |
|
|
Заличен |
3227 |
| C07AG02 |
Carvedilol |
Talliton |
Tablet |
25 |
mg |
30 |
EGIS Pharmaceuticals PLC, Унгария |
37.5 |
mg |
- |
6.89 |
0.212 |
4.24 |
50% |
2.12 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.8,I20.9,I25.5,I50.0,I50.1 |
НСР-3543/16.05.2014.; НСР-6712/16.07.2015.; НСР-14322/03.11.2017; НСР-17783/24.01.2019 |
02.03.2019 |
08.09.2012 |
|
Активен |
2848 |
| C07AG02 |
Carvedilol |
Talliton |
Tablet |
12.5 |
mg |
30 |
EGIS Pharmaceuticals PLC, Унгария |
37.5 |
mg |
- |
3.71 |
0.212 |
2.12 |
50% |
1.06 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.8,I20.9,I25.5,I50.0,I50.1 |
НСР-3544/16.05.2014.; НСР-6711/16.07.2015.; НСР-14324/03.11.2017; НСР-17782/24.01.2019 |
02.03.2019 |
08.09.2012 |
|
Активен |
2847 |
| C07AG02 |
Carvedilol |
Talliton |
Tablet |
6.25 |
mg |
30 |
EGIS Pharmaceuticals PLC, Унгария |
37.5 |
mg |
- |
2.21 |
0.212 |
1.06 |
50% |
0.53 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.8,I20.9,I25.5,I50.0,I50.1 |
НСР-3545/16.05.2014.; НСР-6710/16.07.2015.; НСР-16961/12.10.2018 |
02.11.2018 |
08.09.2012 |
|
Активен |
2846 |
| C07AG02 |
Carvedilol 100% |
C07AG02 Carvedilol 100% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C07AG02 |
Carvedilol |
Avernol |
Tablet |
25 |
mg |
30 |
Medochemie Ltd., Кипър |
37.5 |
mg |
3.56 |
- |
0.178 |
3.56 |
100% |
3.56 |
|
I10 |
HCP-8780/13.04.2016. |
02.08.2019 |
08.09.2012 |
|
Активен |
3118 |
| C07AG02 |
Carvedilol |
Avernol |
Tablet |
6.25 |
mg |
30 |
Medochemie Ltd., Кипър |
37.5 |
mg |
2 |
- |
0.178 |
0.89 |
100% |
0.89 |
|
I10 |
HCP-8780/13.04.2016. |
02.08.2019 |
08.09.2012 |
|
Активен |
3117 |